Long-term Data Collection for Subjects in MDX-010 Studies
Public ClinicalTrials.gov record NCT00928031. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Collection of Long-Term Outcome Data for Subjects Who Have Previously Participated in Selected Ipilimumab (MDX-010) Studies in Metastatic Melanoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to collect disease status and overall survival information for all Subjects in MDX-010 studies.
Study identification
- NCT ID
- NCT00928031
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 160 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2007
- Primary completion
- Mar 31, 2009
- Completion
- Mar 31, 2009
- Last update posted
- Apr 25, 2010
2007 – 2009
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Cancer Center | Tuscon | Arizona | 85724 | — |
| Pacific Shores Medical Group | Long Beach | California | 90813 | — |
| The Angeles Clinic and Research Institute | Los Angeles | California | 90025 | — |
| USC Norris Cancer Center | Los Angeles | California | 90033 | — |
| University of Miami Sylvester Cancer Center | Miami | Florida | 33136 | — |
| St. Francis Research Foundation | Beech Grove | Indiana | 46107 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02115 | — |
| NYU Cancer Institute | New York | New York | 10016 | — |
| Carolinas Cancer Care | Charlotte | North Carolina | 28211 | — |
| Providence Portland Medical Center | Portland | Oregon | 97213 | — |
| Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Metastatic Melanoma trials
Other public records listing Metastatic Melanoma. Sorted by last update posted; newest first. Not a recommendation.
- NCT01644591: Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases Active, not recruiting
- NCT05629546: Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors Recruiting
- NCT04771520: Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors Recruiting
- NCT05655312: MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma Recruiting
- NCT07237594: IL-17 Blockade to Decrease irAEs (REPLAY) Recruiting
- NCT05779423: Cryoablation+Ipilimumab+Nivolumab in Melanoma Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00928031, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 25, 2010 · Synced Sep 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00928031 live on ClinicalTrials.gov.